U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541898) titled 'Effects of Berberine on Cardiometabolic Outcomes' on April 14. Brief Summary: Cardiovascu... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541482) titled 'Pilot Randomized Trial of BA-GSH in VA PC-MHI' on April 14. Brief Summary: Symptoms of de... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07543029) titled 'Kangaroo Care: Breastfeeding Success and Maternal Role' on April 14. Brief Summary: Purpo... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541664) titled 'Digital Mind-Body Therapy for Neoadjuvant Breast Cancer' on April 08. Brief Summary: This... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542782) titled 'Pancreatic Resection in Fit Octogenarians With Nonmetastatic Pancreatic Cancer' on April 1... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541625) titled 'Effect of Scanning Technology on Internal Fit of Digitally Customized Intra-radicular Atta... Read More
U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07542496) titled 'Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Bre... Read More
Singapore, April 22 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 22 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 22 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More